The morphological distinction between reactive and malignant processes in lymph nodes may sometimes be extremely difficult, but theintroduction ofimmunohistochemical methods may help. While a polyclonal cell proliferation may be neoplastic,l it is more generally reactive, but monoclonality is very suggestive of malignancy.
The identification of monoclonality is presently limited to cells of the B lymphocyte series, most simply using antisera to kappa, lambda, and heavy chains. The antigenicity of cellular immunoglobulin appears least impaired in frozen sections or imprints, but in most cases lymphoid material arriving for histopathological diagnosis has been fixed. Routine formalin fixation may not be the most suitable for many antigens, and efforts using proteolytic enzymes to 'unmask' antigenic sites2 presumed concealed by formalin fixation have gone some way to overcoming this problem. When formalin fixation is unavoidable the demonstration of cellular immunoglobulin may require such manipulations, but a more logical approach might be to use a fixative that does not denature or conceal the antigenic sites to the extent whereby reaction between antibody and antigen is impaired. We decided to examine a range of common fixatives to seek any giving adequate morphologica preservation of lymphoid tissue together with preservation of immunoglobulin antigenicity.
Material and methods

TISSUES
Three to four millimetre slices of both human lymph nodes and tonsils and rabbit lymph node, spleen, and gut were fixed for periods up to two weeks in the fixatives given below. Sections were assessed blindly (code labelled by a colleague) by both of us separately for specific staining and for non-specific or background staining, grading each from 0 (no staining) to + + + (strongly stained).
Results
The greatest number of positively staining cells was seen in human tonsils and rabbit small intestine.
The best results were found consistently with Susa and the worst with 10% neutral buffered formalin. The Table shows Letters to the Editors Antibody-coated bacteria in urine A simple, reliable, non-invasive test to differentiate between infections of the upper and lower urinary tract would be of great value, and in the February issue Mengoli and co-workers' repeated the claim that a test for antibody-coated bacteria in the urine can differentiate these infections. However, their evidence is not based on direct localisation of the infection by a method such as bladder washout.2 In addition, they have ex plicitly studied highly selected groups of patients, discarding, for example, some patients thought to have non-obstructive pyelonephritis.
We have found only three published studies that correlate the site of urinary tract infection, localised by a direct method, and the presence or absence of antibody-coated bacteria in the urine. Jones et al.3 studied 29 adults with urinary tract infections, many of them with known underlying disease such as nephrolithiasis. They found good correlation between upper tract infections and the presence of antibody-coated bacteria. A German study4 found similar results in 26 patients, some known to have renal disease. Hellerstein and others5 carried out a prospective study in children. They found antibody-coated bacteria in the urine to have no correlation with the site of urinary tract infection in 45 children.
We also performed a prospective study but in women on general medical wards, selected only by the growth from a urine sample of a coliform organism in a count of at least 1O, per ml. Sixteen women were studied, with a mean age of 70 years. Their medical problems included heart failure, stroke, and uncontrolled diabetes mellitus. The site of infection was determined by a direct method2 that involved drainage of the bladder through a catheter and instillation of an enzyme preparation followed by an antibiotic (we used 125 000 units of streptokinase-streptodornase in 10 ml water followed after 15 minutes by 40 mg gentamicin in 50 ml of 2-74 % sodium bicarbonate, left for 30 minutes). The bladder was then drained and irrigated several times with saline. Samples of the last part of the washout fluid, and at 10, 20, and 30 minutes after the washout, were taken for viable counts. Criteria for diagnosing upper or lower urinary tract infections from these counts have been given.2 3 5 Antibody-coated bacteria were looked for in the patient's urine using sheep anti-human globulin conjugated with fluorescein.6 Controls were overnight subcultures of bacteria from the same urine treated in the same way.
We found eight infections of the upper urinary tract. Of these, five had antibodycoated bacteria. There were five lower tract infections, four having antibodycoated bacteria. Three bladder washout tests gave equivocal results, including two in which the infection was due to a mixture of a coliform and an enterococcus. The other equivocal test was associated with antibody-coated bacteria.
We concluded that the test for antibodycoated bacteria was of no value in determining the site of infection in our patients, selected not because they were known to have long-standing urinary tract disease (as were many of those of Mengoli, l Jones, 3 and Kohnle4) , but only because they had bacteriuria (as were those of Hellerstein5). Any explanation for the discrepancy between the results of these studies must be speculative at the moment but may include factors such as duration of infection, number of previous infections, and immune competence of the patient. How the patients were selected for study is the most important factor.
We suggest that the test for antibodycoated bacteria by itself is misleading in the investigation of an individual patient with urinary tract infection.
